A Meeting of the Minds
This is the big one. It's where results for two major studies of glycemic control in people with type 2 diabetes—ADVANCE and the VA Diabetes Trial—will be revealed, and it's where experts will ponder the implications of another glycemic control study, ACCORD, and its surprising findings of higher death rates among study subjects with type 2 in the tight blood glucose control group. In addition, researchers will be talking about the future of islet cell transplantation, early insulin treatment in type 2, and hundreds of other crucial issues in diabetes treatment and research.
The 68th annual American Diabetes Association Scientific Sessions are being held June 6 through June 10 in San Francisco. More than 13,000 research scientists, physicians, endocrinologists, nurses, dietitians, pharmacists, and other health care professionals are meeting for five days of presentations, panel discussions, and more. To get the scoop straight from the experts, visit www.scientificsessions.diabetes.org. You can also read daily blogs from former USA Today reporter Anita Manning and ADA Youth Advocate Tesch West at diabetes.org/ssblog. And stay tuned for coverage in Diabetes Forecast.